Analyzing Imperva (IMPV) and Ability (NASDAQ:ABIL)

Imperva (NASDAQ: IMPV) and Ability (NASDAQ:ABIL) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations and dividends.

Profitability

This table compares Imperva and Ability’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Imperva 7.11% -3.28% -1.94%
Ability -364.52% -252.84% -50.65%

Risk & Volatility

Imperva has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Comparatively, Ability has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500.

Earnings and Valuation

This table compares Imperva and Ability’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Imperva $321.72 million 4.69 $22.86 million $0.68 63.68
Ability $16.51 million 0.51 -$8.05 million N/A N/A

Imperva has higher revenue and earnings than Ability.

Institutional & Insider Ownership

2.1% of Ability shares are held by institutional investors. 1.1% of Imperva shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings for Imperva and Ability, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Imperva 2 4 8 0 2.43
Ability 0 1 0 0 2.00

Imperva currently has a consensus target price of $52.36, suggesting a potential upside of 20.93%. Ability has a consensus target price of $1.30, suggesting a potential downside of 60.37%. Given Imperva’s stronger consensus rating and higher possible upside, equities analysts plainly believe Imperva is more favorable than Ability.

Summary

Imperva beats Ability on 11 of the 12 factors compared between the two stocks.

Imperva Company Profile

Imperva, Inc. provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services. Its Imperva SecureSphere provides database, file and Web application security across various physical and virtual systems in data centers, including in private, public and hybrid cloud computing environments. Its Imperva Incapsula product line provides cloud-based Website security, denial of service protection and performance solutions. Its Imperva Camouflage creates realistic, functional data for development, testing, and training by disguising sensitive information, while maintaining the characteristics of the original data.

Ability Company Profile

Ability Inc. is a holding company. The Company operates through its subsidiaries, Ability Computer & Software Industries Ltd. and Ability Security Systems Ltd., which provide interception, geolocation and cyber intelligence tools for security and intelligence agencies, military forces, law enforcement agencies and homeland security agencies around the world. The Company is engaged in off-air interception of voice, short message service (SMS), and data communication from both cellular and satellite communication networks, and deciphering solutions for both cellular and satellite communications. The Company’s product categories include Cellular Interception, Cellular Counter Interception, Satellite Interception, Geolocation, Cyber and Crime Prevention. Its Cellular Interception systems include Ultimate Interceptor (ULIN), IBIS, TouchDown, ACIS, AGIS-51 and 3G-Cat. Its Satellite Interception systems include IRIS, ATIS and SLIS.

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Tampa Bay Starting Relievers In Place of Starters
Tampa Bay Starting Relievers In Place of Starters
Teen Juan Soto Hits Home Run in First At-Bat
Teen Juan Soto Hits Home Run in First At-Bat
Ji-Man Choi Receives Another Chance in Milwaukee
Ji-Man Choi Receives Another Chance in Milwaukee
Marlins vs Dodgers sets a 10-year record in MGM sportsbooks
Marlins vs Dodgers sets a 10-year record in MGM sportsbooks
Strikeouts Once Again Plaguing Cubs
Strikeouts Once Again Plaguing Cubs
Atlanta Braves: A Mix of Young and Old
Atlanta Braves: A Mix of Young and Old


Leave a Reply

 
© 2006-2018 BBNS.